![PFL 4 Weigh-ins Joilton Lutterbach PFL](https://cagesidepress.com/wp-content/uploads/2024/08/Joilton-Lutterbach.jpg)
Brazilian middleweight Joilton Lutterbach has yet to set foot inside the UFC octagon, but he’s been handed a two-year suspension from competition nonetheless.
Lutterbach (38-10) was supposed to have faced Shara Magomedov back in June at UFC Saudi Arabia. The 31-year old veteran of nearly 50 MMA bouts (not to mention boxing, kickboxing, Karate Combat and Muay Thai beyond that) was pulled from the card, however.
Now, CSAD (Combat Sports Anti-Doping), the UFC-backed body that oversees their drug testing program these days, has announced that Lutterbach has been hit with a two-year sanction after testing positive for 3a-Hydroxy-2a-methyl-5a-androstan-17-one, a metabolite of drostanolone, an anabolic steroid.
The substance is banned from use by UFC athletes at all times under the promotion’s Anti-Doping Policy (ADP).
Of note, Joilton Lutterbach, who previously competed for the PFL, later admitted to extensive use of the steroid, despite being given the opportunity to declare such usage during his onboarding process with the UFC.
Per a press release on the matter, “Upon being notified by UFC personnel of the positive test on June 20, 2024, at the UFC host hotel in Saudi Arabia, Lutterbach admitted to extensive use of drostanolone in the months before he was signed to a UFC contract. Upon being added to the UFC Anti-Doping Program, all athletes are required to declare the use of any prohibited substances they have used over the last 12 months. An athlete who makes such a declaration will not be deemed to have committed a violation, but depending on the substance and circumstances, may be required to refrain from competition for a period of at least 180 days and provide at least two negative sample results. Lutterbach did not declare his use of drostanolone on his onboarding declaration form while admitting that he realized he should have done so.”
Lutterbach’s suspension has been backdated to June, and will expire in 2026. He won’t be setting foot in the octagon then, however. “Immediately after the return of this result and Lutterbach’s admission of the use of drostanolone, the UFC terminated his contract.”